University of Colorado Cancer Center study shows that radiosurgery may effectively treat brain metastases associated with certain types of lung cancer, even when the number of metastases exceeds established norms.
An online survey of 900 consumers of three of the United States’ most popular cigarette brands suggests that adopting standardized cigarette packing may reduce consumers’ misconceptions that some cigarettes are less harmful than others, reports a team of researchers led by University of California San Diego School of Medicine and published in BMJ Tobacco Control.
SEATTLE – (Dec. 18, 2017) –Virginia Mason has become the first health system in Washington state to begin a new therapy that targets neuroendocrine tumors, an uncommon cancer that affects the intestines, pancreas, lungs and other parts of the body.
Tomorrow, ministers at the 15th ministerial council meeting of the Energy Community in Kosovo will adopt new rules for emission limits for coal power plants in the Western Balkans (as part of the transposition of the EU’s Industrial Emissions Directive into national law).
Researchers at The Johns Hopkins University report statistical evidence that children exposed to airborne coarse particulate matter — a mix of dust, sand and non-exhaust tailpipe emissions, such as tire rubber — are more likely to develop asthma and need emergency room or hospital treatment for it than unexposed children.
Children exposed to coarse particulate matter may be more likely to develop asthma and to be treated in an ER or be hospitalized for the condition, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have identified a promising solution to improving treatments offered to patients with cystic fibrosis.
This past weekend brought fierce Santa Ana Winds to Southern California that are expected to last all week. As of this writing, major fires are burning in Ventura County and other areas within Los Angeles County. The South Coast Air Quality Management District lists the following areas of direct smoke impacts: ftp://ftp.aqmd.gov/pub/globalist/Advisory2.pdf
Remember when your mom always told you “what you do now will catch up with you when you’re older?” She wasn’t lying. Lung cancer is a disease that mostly affects the elderly, with 83 percent of those living with cancer being 60-years-of-age or older, but reducing your risk of getting lung cancer starts when you’re young.
Dec. 5, 2017─Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research published online in the Annals of the American Thoracic Society.
Ann & Robert H. Lurie Children’s Hospital of Chicago is one of the study sites in the open label Phase 3 study that showed safety and effectiveness of the cystic fibrosis drug Kalydeco (ivacaftor) in children ages 1 to 2 years. Based on these results, Vertex Pharmaceuticals Inc., (Nasdaq: VRTX) plans to submit applications for the drug in this age group to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Kalydeco is currently approved by the FDA for the treatment of cystic fibrosis in patients aged 2 years and older.
DNA sequences between mitochondria within a single cell are vastly different, found researchers. This knowledge will help to better illuminate the underlying mechanisms of many disorders that start with accumulated mutations in individual mitochondria and provide clues about how patients might respond to specific therapies.
A team of physicians, scientists and biostatisticians from La Jolla Institute for Allergy and Immunology and UC San Diego School of Medicine joined forces across institutions to successfully compete for an $6.9 million grant to establish one of only 10 PrecISE Network Clinical Centers nationwide.
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.
TIna Farber arrived in Arkansas with one thing on her mind — meeting her two new grandbabies. Her son’s third child had arrived in April, and her daughter was expecting her third about one month later.
Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition — which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment — are more likely to invade and spread to other parts of the body, according to a new study led by researchers from Mass. Eye and Ear, Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard.
Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, achieved robust anti-tumor responses in human cancer cell lines and mice.
Patients with early stage lung cancer live longer when they receive a lobectomy—the most common type of operation for the disease—rather than a less extensive operation or radiation treatment.
A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health.
The study from the University of Notre Dame and Michigan State University could help researchers identify how to tone down the ability of mycobacteria to cause disease and help them in treating infection.
While new CF drugs are life-changing for some patients, they don’t work for everyone. Now, UNC and UAB researchers present a simple test that aims to predict which treatment is most likely to work for each patient, an approach known as personalized or precision medicine.
A large multicenter study found that patients with cystic fibrosis (CF) – who tend to develop chronic lung infections – had more good and bad bacteria in their lungs compared to controls. The study used bronchoalveolar lavage, in which a bronchoscope is directed into the lung to directly collect lung secretions, and also found less diversity of bacteria in the lungs of CF patients who were older and had more lung disease or inflammation. Results, published in the European Respiratory Journal, provide a basis for future treatment studies.
Sinus infections, inflammation and nasal congestion constantly plague Americans, often leading to unpleasant symptoms and even missed days of work. Traditional nasal spray anti-inflammatory medications attempt to treat the symptoms noninvasively, but are not very efficient in transmitting the active drug ingredients directly into the sinus cavities. Researchers from the University of North Carolina will present their research on the anatomy-based flow physics in nasal cavities which generate “magical” streamlines for sinus drug delivery at the 70th meeting of the Division of Fluid Dynamics, Nov. 19-21, 2017.
UNC School of Medicine researchers have developed a new laboratory model to measure and compare the responses of CF and normal airway cells to CF-related infectious/inflammatory factors.
The American Thoracic Society (ATS) and the Japanese Respiratory Society (JRS) have published additional clinical practice guidelines regarding four specific questions related to the diagnosis of lymphangioleiomyomatosis (LAM) and management of pneumothoraces in patients with LAM.
The court-ordered publication of “corrective statements” by major U.S. tobacco companies later this month should serve as a reminder that tobacco addiction remains a major health problem in the country and that Big Tobacco has a long history of marketing practices aimed at hooking a new generation on a lethal product, according to an editorial published online in the Annals of the American Thoracic Society.
New research from the University of Maryland School of Medicine suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant and therefore, may mislead clinicians.
A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant “driver” mutation that can be treated in isolation with a single targeted drug.
Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?
An article in the Annals of Allergy, Asthma and Immunology guides medical professionals through the principles involved in using new treatments for severe asthma.
New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.
Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.
The ATS Foundation continues to support researchers committed to improving the lives of patients with respiratory disease. Today, the Foundation announces its new ATS Foundation/Boehringer Ingelheim Research Fellowship in idiopathic pulmonary fibrosis. The fellowship will award $100,000 over two years.
Studies show a two-drug combination therapy for cystic fibrosis, using tezacaftor and ivacaftor, is effective. UAB researchers say triple combination therapy is close behind.
A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit to patients in most case
Researchers have known for decades that exposure to radon may cause lung cancer, and that North Dakota and Iowa have some of the highest radon rates in the country.
Could radon potentially cause other cancers? Researchers from the geography department and the School of Medicine & Health Sciences teamed up to explore that possibility.
Along with a high incidence of radon, North Dakota also has the highest rate in the nation of chronic lymphocytic leukemia, or CLL. No one knows what causes this cancer, which usually is found in people over age 70. It is not curable but is treatable for some patients. Could there be a correlation?
Rush University Medical Center’s lung cancer care team is one of two programs that provide the highest-quality lung cancer care in North America, according to the International Association for the Study of Lung Cancer (IASLC), which chose Rush as one of five worldwide recipients of the foundation’s inaugural Cancer Care Team Award. Acknowledging cancer care teams across the globe who go above and beyond to provide the highest-quality patient care, the award is unique in that the recipients were nominated by patients.
Because its symptoms are similar to those of other viruses – coughing, sneezing, runny nose, fever, irritability and loss of appetite – RSV is considered the most common illness that many parents have never heard of. While in many healthy babies, RSV may not develop into a more serious illness, it is the most common cause of bronchiolitis and pneumonia in children younger than one year of age in the United States, making it the most frequent cause of hospitalization for infants.
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.
Asthma and allergies are related, and many people who suffer from asthma have allergies that trigger their asthma. Research being presented at the American College of Allergy, Asthma and Immunology’s (ACAAI) Annual Scientific Meeting examines the relationship between medical history and allergic reactionsin children, and how long they stayed in the hospital after an asthma attack.
If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults. Although many adults with atopic dermatitis (commonly known as eczema)develop the disease in childhood and carry it through life, a large number are first diagnosed in adulthood – atrend being discussed at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting.
“Good dog!” Two studies being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting show there may be even more reason to love your dog. The first study shows babies born in a home with a dog – during pregnancy and early infancy – receive protection from allergic eczema, though the protective effect goes down by age 10. A second study shows dogs may provide a protective effect against asthma, even in children allergic to dogs.